12 studies found for:    "angelman syndrome"
Show Display Options
Rank Status Study
1 Completed A Trial of Levodopa in Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: Levodopa/carbidopa
2 Recruiting Characterization of Angelman Syndrome
Condition: Angelman Syndrome
Intervention:
3 Completed Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: Levodopa/Carbidopa (4:1)
4 Active, not recruiting Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: MINOCYCLINE;   Drug: PLACEBO (for Minocycline)
5 Active, not recruiting Minocycline in the Treatment of Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: minocycline
6 Completed
Has Results
Dietary Supplements for the Treatment of Angelman Syndrome
Conditions: Angelman Syndrome;   Nervous System Diseases
Interventions: Drug: Betaine;   Drug: Creatine;   Drug: Metafolin;   Drug: Vitamin B12
7 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
Intervention:
8 Not yet recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
Intervention:
9 Active, not recruiting Genomic Imprinting and Assisted Reproductive Technologies
Conditions: Natural Pregnancy;   Pregnancy, Ovarian
Intervention:
10 Withdrawn An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Intervention: Drug: EPI-743
11 Recruiting Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Condition: Sleep Disorders
Interventions: Drug: Circadin 2/5/10 mg;   Drug: Placebo
12 Completed Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Condition: Sleep Problems
Interventions: Drug: Circadin 2 mg;   Drug: Circadin 10 mg

Indicates status has not been verified in more than two years